Risk factors for hip fracture among elderly patients with Parkinson’s disease

Incidence of hip fracture among patients with Parkinson's disease (PD) is high, especially in elderly women. To determine effects of various factors on hip fracture risk, we prospectively studied fractures in a cohort of 115 elderly patients of both genders with PD (46 men, 69 women; mean age, 71.9 years) for 1 year. At baseline, we recorded body mass index (BMI), Hoehn and Yahr stage, and postmenopausal interval, and also measured bone mineral density (BMD) and serum concentrations of ionized calcium, intact parathyroid hormone (PTH), pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP; a bone resorption marker), and 25-hydroxyvitamin (25-OHD). During the year hip fractures occurred in 18 patients (2 male and 16 female). We compared baseline variables between patients with and without hip fracture. PD patients with decreased BMI, lower BMD, and low concentrations of serum ionized calcium, and 25-OHD (mean 4.0 ng/ml) with compensatory hyperparathyroidsim had increased risk of hip fracture. Female PD patients with long postmenopausal intervals also had increased hip fracture risk. BMI, illness duration, postmenopausal intervals, Hoehn and Yahr stage, 25-OHD, PTH, calcium, and ICTP were determinants of BMD in patients with fracture. Elderly PD patients with low BMI, low BMD, and serum 25-OHD concentrations < or =5 ng/ml with secondary hyperparathyroidism have increased risk of hip fracture, as do female PD patients with long postmenopausal intervals.

[1]  W. Koller,et al.  Falls and Parkinson's disease. , 1989, Clinical neuropharmacology.

[2]  Yoshihiro Sato,et al.  Amelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1 alpha-hydroxyvitamin D3 and calcium supplementation. , 1997, Stroke.

[3]  D. MacLeod,et al.  uantitative measurements of osteoid in health and disease. , 1969, Clinical orthopaedics and related research.

[4]  V. Crawford,et al.  Reduced bone density of the hip in elderly patients with Parkinson's disease. , 1995, Age and ageing.

[5]  François Duboeuf,et al.  Vitamin D3 and Calcium to Prevent Hip Fractures in Elderly Women , 1992 .

[6]  A. Ramnemark,et al.  Fractures after Stroke , 1998, Osteoporosis International.

[7]  F. Biering-Sørensen,et al.  Longitudinal study of bone mineral content in the lumbar spine, the forearm and the lower extremities after spinal cord injury , 1990, European journal of clinical investigation.

[8]  L. Chia,et al.  Bone mineral density in patients with Parkinson's disease measured by dual photon absorptiometry , 1994, Nuclear medicine communications.

[9]  R. Tardiman,et al.  Hip fractures in patients with Parkinson's syndrome. , 1983, The Journal of trauma.

[10]  Yoshihiro Sato,et al.  Amelioration of osteopenia and hypovitaminosis D by 1α-hydroxyvitamin D3 in elderly patients with Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[11]  S. P. Chow,et al.  Sequential fractures of both hips in elderly patients--a prospective study. , 1992, The Journal of trauma.

[12]  L. Klenerman,et al.  Fractured neck of femur in the elderly: an attempt to identify patients at risk. , 1979, Clinical science.

[13]  Yoshihiro Sato,et al.  High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease [RETRACTED] , 1997, Neurology.

[14]  A. F. Stewart,et al.  Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. , 1982, The New England journal of medicine.

[15]  K. Oizumi,et al.  Effect of ipriflavone on bone in elderly hemiplegic stroke patients with hypovitaminosis D. , 1999, American journal of physical medicine & rehabilitation.

[16]  J L Kelsey,et al.  Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. , 1991, The New England journal of medicine.

[17]  Yoshihiro Sato,et al.  Influence of immobilization on bone mass and bone metabolism in hemiplegic elderly patients with a long-standing stroke , 1998, Journal of the Neurological Sciences.

[18]  P. Delmas,et al.  Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  G. D. Whedon,et al.  Vitamin D and bone health in the elderly. , 1982, The American journal of clinical nutrition.

[20]  J. Templeton,et al.  Hip fractures in patients with Parkinson's disease. , 1980, Clinical orthopaedics and related research.

[21]  P. Millard,et al.  Vitamin D status of patients with femoral neck fractures. , 1976, Age and ageing.

[22]  L. Avioli,et al.  Subclinical vitamin D deficiency in postmenopausal women with low vertebral bone mass. , 1991, The Journal of clinical endocrinology and metabolism.

[23]  F. Ishizaki,et al.  Relationship between osteopenia and clinical characteristics of parkinson's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.

[24]  O Johnell,et al.  Fracture risk in patients with parkinsonism: a population-based study in Olmsted County, Minnesota. , 1992, Age and ageing.

[25]  J. Aita,et al.  Why patients with Parkinson's disease fall. , 1982, JAMA.

[26]  L. Mosekilde,et al.  Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.